Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

Esteve, M.; Saro, C.; González-Huix, F.; Suarez, F.; Forné, M.; Viver, J. M.
September 2004
Gut;Sep2004, Vol. 53 Issue 9, p1363
Academic Journal
Background: There is little information about the effect of infliximab on the clinical course of liver disease in Crohn's disease patients with concomitant hepatitis B virus (HBV) infection. Theoretically, immunosuppression induced by infliximab will facilitate viral replication which could be followed by a flare or exacerbation of disease when therapy is discontinued. There are no specific recommendations on surveillance and treatment of HBV before infliximab infusion. Two cases of severe hepatic failure related to infliximab infusions have been described in patients with rheumatic diseases. Patients and methods: Hepatitis markers (C and B) and liver function tests were prospectively determined to 80 Crohn's disease patients requiring infliximab infusion in three hospitals in Spain. Results: Three Crohn's disease patients with chronic HBV infection were identified. Two of the three patients with chronic HBV infection suffered severe reactivation of chronic hepatitis B after withdrawal of infliximab therapy and one died. A third patient, who was treated with lamivudine at the time of infliximab therapy, had no clinical or biochemical worsening of liver disease during or after therapy. From the remaining 80 patients, six received the hepatitis B vaccine. Three patients had antibodies to both hepatitis B surface antigen (anti-HBs) and hepatitis B core protein (anti-HBc) with normal aminotransferase levels, and one patient had positive anti-hepatitis C virus (HCV) antibodies, negative HCV RNA, and normal aminotransferase levels. Except for the patients with chronic HBV infection, no significant changes in hepatic function were detected. Conclusions: Patients with Crohn's disease who are candidates for infliximab therapy should be tested for hepatitis B serological markers before treatment and considered for prophylaxis of reactivation using antiviral therapy if positive.


Related Articles

  • Orthohepadnavirus. Jing-Hsiung Ou // Springer Index of Viruses;2002, p373 

    The article presents information on the Orthohepadnavirus under the Hepadnaviridae family of viruses. It outlines the virion, genome and replication strategy of the virus. An overview of the genus members of the virus, including human hepatitis B virus, ground squirrel hepatitis B virus and...

  • Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs. Y- M Wen; X Lin; Z- M Ma // Current Drug Targets - Infectious Disorders;Sep2003, Vol. 3 Issue 3, p241 

    Based on the recent studies of HBV strains with different replication efficiency, several new potential targets for anti-HBV replication have been presented. These include the viral and cellular regulatory factors associated with HBV replication and the process for encapsidation of viral genome...

  • Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition. Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    RNA interference (RNAi) of virus-specific genes offers the possibility of developing a new anti-hepatitis B virus (anti-HBV) therapy. Recent studies have revealed that siRNAs can induce an innate immune response in vitro and in vivo. Here, HBVx (HBx) mRNA expression and HBV replication were...

  • Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro. Yong-Wen He; Chun-Xia Guo; Yan-Feng Pan; Cheng Peng; Zhi-Hong Weng; Reiser, Markus; Menne, Stephan; Gretch, David R. // World Journal of Gastroenterology;3/14/2008, Vol. 14 Issue 10, p1592 

    AIM: To explore the inhibitory effects of pokeweed antiviral protein seed (PAP-S) and PAP encoded by a eukaryotic expression plasmid on hepatitis B virus (HBV) replication in vitro. METHODS: HepG2 2.2.15 cells in cultured medium were treated with different concentrations of PAP-S. HBsAg, HBeAg...

  • A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China. Tao-Tao Liu; Ying Fang; Hui Xiong; Tao-Yang Chen; Zheng-Pin Ni; Jian-Feng Luo; Nai-Qing Zhao; Xi-Zhong Shen; Xin-Xin Zhang // World Journal of Gastroenterology;5/21/2008, Vol. 14 Issue 19, p3059 

    AIM: To investigate the role of hepatitis B virus (HBV) replication in the development of hepatocellular carcinoma (HCC), a nested case-control study was performed to study the relationship between HBV DNA level and risk of HCC. METHODS: One hundred and seventy cases of HCC and 276 control...

  • Targeting of a Host Protein to Suppress Hepatitis B Virus Replication.  // PLoS Medicine;Jul2005, Vol. 2 Issue 7, p574 

    Discusses research being done on host heterogeneous ribonucleoprotein K as a potential target to suppress hepatitis B virus (HBV) replication. Reference to a study by Lisa F. P. Ng et al, published in the July 2005 issue of "PLoS Medicine" journal; Effective approach to controlling the...

  • The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Mohamadkhani, Ashraf; Sayemiri, Kourosh; Ghanbari, Reza; Elahi, Elham; Poustchi, Hossein; Montazeri, Ghodratollah // Virology Journal;2010, Vol. 7, p228 

    BACKGROUND: The natural history of hepatitis B virus (HBV) is complex and influenced by the level of viral replication and host factors. The hepatoprotective role of high density lipoproteins (HDL) and adiponectin as host factors on HBV persistence is less well understood. METHODS: To...

  • Dengue causing fulminant hepatitis in a hepatitis B virus carrier. Agarwal, Mukul P.; Giri, Subhash; Sharma, Vishal; Roy, Ujjawal; Gharsangi, Komal // BioScience Trends;Feb2011, Vol. 5 Issue 1, p44 

    Dengue is an acute febrile illness resulting from infection by a flavivirus transmitted by the Aedes mosquito. It is characterized by bleeding manifestations and a plasma leak syndrome. Hepatic involvement in the form of elevation in transaminases is common. However, acute hepatic failure is...

  • Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.  // BMC Gastroenterology;2012, Vol. 12 Issue 1, p43 

    The article discusses a study conducted to know the significance of T (Treg) cells and interlukin-17-producing T help cells (Th17) balance in the development of acute and chronic hepatitis B virus (HBV) infection. IT has been informed that the study results found that Th17 cells are involved in...


Read the Article


Sign out of this library

Other Topics